Tumor necrosis factor reduces c-myc expression and cooperates with interferon-gamma in HeLa cells

Area of Science:

• Molecular biology
• Cell cycle regulation
• Oncogene research

Background:

• The c-myc oncogene plays a crucial role in cell proliferation.
• Naturally occurring growth inhibitors are hypothesized to control c-myc expression.
• Cytokines like TNF and IFN-gamma can induce cell cycle arrest.

Purpose of the Study:

• To investigate the effects of TNF and IFN-gamma on c-myc expression in HeLa cells.
• To elucidate the molecular mechanisms underlying cytokine-mediated c-myc suppression.
• To determine if TNF and IFN-gamma act synergistically or independently.

Main Methods:

• HeLa cells were treated with TNF and/or IFN-gamma.
• Northern blot analysis was used to quantify c-myc messenger RNA (mRNA) levels.
• Nuclear transcription assays assessed the rate of c-myc gene transcription.
• Experiments included the use of cycloheximide to assess protein synthesis dependence.

Main Results:

• Both TNF and IFN-gamma significantly reduced c-myc mRNA levels within 1-3 hours via transcriptional inhibition.
• Combined treatment with TNF and IFN-gamma resulted in enhanced inhibition of c-myc transcription and mRNA levels.
• IFN-gamma's effect required new protein synthesis, whereas TNF's effect was direct and cycloheximide-resistant.
• Differential responses to protein synthesis inhibition and synergistic effects suggest distinct molecular mechanisms.

Conclusions:

• TNF and IFN-gamma effectively suppress c-myc oncogene transcription in HeLa cells.
• The cytokines exhibit distinct molecular mechanisms in inhibiting c-myc expression.
• The cooperative inhibition suggests potential therapeutic strategies targeting c-myc in cancer.